We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

MRI: breast cancer

An Institute of Cancer Research success story.

Under the NHS R&D Priorities in Cancer Programme, the Clinical Magnetic Resonance Research Group led a multi-centre trial of dynamic MRI as a method of screening women at genetic risk of breast cancer.

This study demonstrated that MRI provides an effective means of screening women at high risk of breast cancer.

Published in 2005, it showed that MRI was twice as sensitive as X-ray mammography in detecting cancer in women who had a 50 per cent risk of carrying a breast cancer predisposition gene mutation.

The paper 'Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study' was published in 'The Lancet' on 21 May 2005.

Find out more about The Institute of Cancer Research.

Image credit: Breast cancer cell; Anne Weston

Share |
Home  >  Funding  >  Biomedical science  >  Funded projects  >  Major initiatives  >  Clinical Research Facilities  > Using MRI for screening women at risk of breast cancer
Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888